A compact Cas12f nuclease shows high editing efficiency in human cells, with structural insights enabling an engineered variant potentially suited for future AAV‑compatible delivery.

The scientists driving Neion Bio’s effort to engineer chickens as scalable, lower-cost platforms for biologics manufacturing.

Scientists have taken an important step toward a gene therapy that could one day turn off the extra genetic material that ...

In 2025, baby KJ Muldoon became the first person to receive a personalized gene editing treatment, which likely saved his ...